• GLYCOPYRROLATE CHEMBL1201335 FDA ApprovedAntineoplastic

    Alternate Names:

    Robanul
    Glycopyrronium
    Utibron Neohaler
    Ultibro Breezhaler
    Tarodyl
    Seebri Neohaler
    Seebri Breezhaler
    Robinul-forte Tab 2mg
    Robinul Tab 1mg
    Robinul Forte Tab 2mg
    Robinul Forte
    Robinul 0.2mg/ml Liq Inj
    Robinul
    Robinal
    Nodapton
    Glycopyrrolate Injection USP
    Glycopyrrolate Injection Multidose
    Glycopyrrolate Injection
    Glycate
    Cuvposa
    Bevespi Aerosphere
    Acpan
    740028-90-4
    Glycopyrronium ion
    Glycopyrronium cation
    Glycopyrrolate ion
    Glycopyrrolate cation
    DB00986
    EINECS 209-887-0
    WLN: T5KTJ A1 A1 COVXQR&- AL5TJ &Q &E
    NVA237
    BROMURE DE RITROPIRRONIO
    TARODYN
    1-METHYL-3-PYRROLIDYL ALPHA-PHENYLCYCLOPENTANEGLYCOLATE METHOBROMIDE
    UNII-V92SO9WP2I
    3-HYDROXY-1,1-DIMETHYLPYRROLIDINIUM BROMIDE ALPHA-CYCLOPENTYLMANDELATE
    PYRROLIDINIUM, 3-HYDROXY-1,1-DIMETHYL-, BROMIDE, .ALPHA.-CYCLOPENTYLMANDELATE
    PYRROLIDINIUM, 3-[(CYCLOPENTYLHYDROXYPHENYLACETYL)OXY]-1,1-DIMETHYL-, BROMIDE
    BROMURE DE GLYCOPYRRONIUM
    1-METHYL-3-PYRROLIDINYL .ALPHA.-PHENYLCYCLOPENTANEGLYCOLATE METHOBROMIDE
    NSC 251251
    ST51054976
    NVA 237
    BROMURO DE GLICOPIRRONIO
    RITROPIRRONIUM BROMIDE
    GLYCOPYRRONIUM BROMIDE (JAN/INN)
    AC1LAW54
    GLYCOPYRRONII BROMIDUM
    MANDELIC ACID, .ALPHA.-CYCLOPENTYL-, ESTER WITH 3-HYDROXY-1,1-DIMETHYLPYRROLIDINIUM BROMIDE
    PYRROLIDINIUM, 1,1-DIMETHYL-3-HYDROXY-, BROMIDE, ALPHA-CYCLOPENTYLMANDELATE
    (1,1-DIMETHYLPYRROLIDIN-1-IUM-3-YL) 2-CYCLOPENTYL-2-HYDROXY-2-PHENYLACETATE BROMIDE
    NSC250836
    D00540
    AC-15990
    SAM002589987
    CHEMBL1201027
    MLS002222301
    I14-3643
    PYRROLIDINIUM, 3-HYDROXY-1,1-DIMETHYL-, BROMIDE, ALPHA-CYCLOPENTYLMANDELATE (8CI)
    3-HYDROXY-1,1-DIMETHYLPYRROLIDINIUM BROMIDE-.ALPHA.-CYCLOPENTYLMANDELATE
    MLS001424112
    GASTRODYN
    BROMURE DE RITROPIRRONIUM
    NSC 251252
    RITROPIRRONIUM BROMIDE [INN]
    AC1Q1RGS
    ROBINUL (TN)
    596-51-0
    53808-86-9
    3-HYDROXY-1,1-DIMETHYLPYRROLIDINIUM BROMIDE .ALPHA.-CYCLOPENTYLMANDELATE
    HMS2094A05
    ASECRYL
    GLYCOPYRRONI BROMIDUM
    NVA-237
    COPYRROLATE
    CID11693
    MOLPORT-002-885-831
    BROMURO DE GLICOPIRRONIO [INN-SPANISH]
    .BETA.-1-METHYL-3-PYRROLIDYL-.ALPHA.-CYCLOPENTYLMANDELATE METHOBROMIDE
    CPD000469282
    NSC 250836
    HMS1570E14
    BROMURE DE GLYCOPYRRONIUM [INN-FRENCH]
    NSC251252
    HMS2051P12
    LS-138344
    AC1L1XX0
    PT-001
    GLYCOPYRROLATE (USP)
    C19H28NO3
    AHR-504
    GLYCOPYRROLATE [USAN]
    1,1-DIMETHYL-3-HYDROXYPYRROLIDINIUM BROMIDE ALPHA-CYCLOPENTYLMANDELATE
    GLYCOPYRRONII BROMIDUM [INN-LATIN]
    SMR000469282
    NSC251251
    1,1-DIMETHYL-3-HYDROXYPYRROLIDINIUM BROMIDE .ALPHA.-CYCLOPENTYLMANDELATE
    PYRROLIDINIUM, 3-((CYCLOPENTYLHYDROXYPHENYLACETYL)OXY)-1,1-DIMETHYL-, BROMIDE
    DCL000901
    AD-237
    PYRROLIDINIUM, 3-HYDROXY-1,1-DIMETHYL-, BROMIDE, ALPHA-CYCLOPENTYLMANDELATE
    GLYCOPYRROLATE BROMIDE
    GLYCOPYRRONIUM BROMIDE
    AHR 504
    SAM001246629
    3-(ERYTHRO-2-CYCLOPENTYL-2-HYDROXY-2-PHENYLACETOXY)-1,1-DIMETHYLPYRROLIDINIUMBROMID
    187051762
    7459
    PRESTWICK0_000746
    PRESTWICK1_000746
    SALT*)
    794728
    BSPBIO_000732
    PRESTWICK2_000746
    SPBIO_002671
    DAP001116
    (1,1-DIMETHYLPYRROLIDIN-1-IUM-3-YL) 2-CYCLOPENTYL-2-HYDROXY-2-PHENYLACETATE
    NCGC00179456-01
    BPBIO1_000806
    CID521843
    AB00513912
    CID3494
    AC1L1G28
    L001045
    AR-1J1255
    AC1Q60WT
    PRESTWICK3_000746
    3494

    Drug Info:

    Drug Categories therapeutic uses
    Drug Categories synthetic anticholinergics, quaternary ammonium compounds
    Drug Categories quaternary ammonium compounds
    Drug Categories pyrrolidines
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories organic chemicals
    Drug Categories onium compounds
    Drug Categories nitrogen compounds
    Drug Categories neurotransmitter agents
    Drug Categories muscarinic antagonists
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories inorganic chemicals
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories drugs for functional gastrointestinal disorders
    Drug Categories cholinergic antagonists
    Drug Categories cholinergic agents
    Drug Categories chemical actions and uses
    Drug Categories central nervous system agents
    Drug Categories ammonium compounds
    Drug Categories amines
    Drug Categories alimentary tract and metabolism
    Drug Categories adjuvants, anesthesia
    Drug Groups vet_approved
    Drug Groups investigational
    Drug Groups approved
    Drug Type small molecule
    Drug Class adjuvants, anesthesia
    Year of Approval 1961
    FDA Approval approved
    Drug Class Small molecule
    Drug Indications for treatment of chronic obstructive pulmonary disease (COPD)
    Drug Indications for treatment of chronic obstructive pulmonary disorder (COPD)
    Drug Indications antineoplastic agent
    (3 More Sources)